IT201700057635A1 - Composizione per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico - Google Patents

Composizione per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico

Info

Publication number
IT201700057635A1
IT201700057635A1 IT102017000057635A IT201700057635A IT201700057635A1 IT 201700057635 A1 IT201700057635 A1 IT 201700057635A1 IT 102017000057635 A IT102017000057635 A IT 102017000057635A IT 201700057635 A IT201700057635 A IT 201700057635A IT 201700057635 A1 IT201700057635 A1 IT 201700057635A1
Authority
IT
Italy
Prior art keywords
esophageic
symptoms
extra
treatment
composition
Prior art date
Application number
IT102017000057635A
Other languages
English (en)
Inventor
Luigi Mercuri
Original Assignee
Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L filed Critical Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L
Priority to IT102017000057635A priority Critical patent/IT201700057635A1/it
Priority to EA201992743A priority patent/EA201992743A1/ru
Priority to PCT/IB2018/053514 priority patent/WO2018215897A1/en
Priority to PE2019002445A priority patent/PE20200526A1/es
Priority to UAA201911978A priority patent/UA126580C2/uk
Priority to US16/617,368 priority patent/US20200085854A1/en
Priority to EP18730122.1A priority patent/EP3630064A1/en
Priority to MX2019013917A priority patent/MX2019013917A/es
Priority to MA048955A priority patent/MA48955A/fr
Publication of IT201700057635A1 publication Critical patent/IT201700057635A1/it
Priority to MX2022015182A priority patent/MX2022015182A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
IT102017000057635A 2017-05-26 2017-05-26 Composizione per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico IT201700057635A1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT102017000057635A IT201700057635A1 (it) 2017-05-26 2017-05-26 Composizione per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico
EA201992743A EA201992743A1 (ru) 2017-05-26 2018-05-18 Композиция для применения при лечении экстраэзофагеальных симптомов желудочного рефлюкса
PCT/IB2018/053514 WO2018215897A1 (en) 2017-05-26 2018-05-18 Composition for use in the treatment of extraoesophageal gastric reflux symptoms
PE2019002445A PE20200526A1 (es) 2017-05-26 2018-05-18 Composicion para uso en el tratamiento de sintomas de reflujo gastrico extraoesofagico
UAA201911978A UA126580C2 (uk) 2017-05-26 2018-05-18 Застосування композиції, що містить альгінову та гіалуронову кислоти, для лікування екстраезофагеальних симптомів шлункового рефлюксу
US16/617,368 US20200085854A1 (en) 2017-05-26 2018-05-18 Composition for use in the treatment of extraoesophageal gastric reflux symptoms
EP18730122.1A EP3630064A1 (en) 2017-05-26 2018-05-18 Composition for use in the treatment of extraoesophageal gastric reflux symptoms
MX2019013917A MX2019013917A (es) 2017-05-26 2018-05-18 Composicion para usarse en el tratamiento de sintomas de reflujo gastrico extraoesofagico.
MA048955A MA48955A (fr) 2017-05-26 2018-05-18 Composition destinée à être utilisée dans le traitement des symptômes du reflux gastrique extra- sophagien
MX2022015182A MX2022015182A (es) 2017-05-26 2019-11-21 Composicion para usarse en el tratamiento de sintomas de reflujo gastrico extraesofagico.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000057635A IT201700057635A1 (it) 2017-05-26 2017-05-26 Composizione per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico

Publications (1)

Publication Number Publication Date
IT201700057635A1 true IT201700057635A1 (it) 2018-11-26

Family

ID=60294045

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000057635A IT201700057635A1 (it) 2017-05-26 2017-05-26 Composizione per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico

Country Status (9)

Country Link
US (1) US20200085854A1 (it)
EP (1) EP3630064A1 (it)
EA (1) EA201992743A1 (it)
IT (1) IT201700057635A1 (it)
MA (1) MA48955A (it)
MX (2) MX2019013917A (it)
PE (1) PE20200526A1 (it)
UA (1) UA126580C2 (it)
WO (1) WO2018215897A1 (it)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005105167A1 (de) * 2004-04-16 2005-11-10 Cellmed Ag Injizierbare vernetzte und unvernetzte alginate und ihre verwendung in der medizin und in der ästhetischen chirurgie
WO2009064617A1 (en) * 2007-11-14 2009-05-22 S.K. Pharmaceuticals, Inc. Stabilized glycosaminolglycan preparations and related methods
US20110097367A1 (en) * 2008-01-16 2011-04-28 Cellmed Ag Monolithic in-situ cross-linked alginate implants
EP2545925A1 (en) * 2011-07-12 2013-01-16 Holy Stone Healthcare Co.,Ltd. Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases
WO2018044673A1 (en) * 2016-08-31 2018-03-08 Pharmunion, LLC A nutritional composition of pharmaceutical and dietary supplement containing said nutritional of pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201600121601A1 (it) * 2016-11-30 2018-05-30 Nekkar Lab Srl Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005105167A1 (de) * 2004-04-16 2005-11-10 Cellmed Ag Injizierbare vernetzte und unvernetzte alginate und ihre verwendung in der medizin und in der ästhetischen chirurgie
WO2009064617A1 (en) * 2007-11-14 2009-05-22 S.K. Pharmaceuticals, Inc. Stabilized glycosaminolglycan preparations and related methods
US20110097367A1 (en) * 2008-01-16 2011-04-28 Cellmed Ag Monolithic in-situ cross-linked alginate implants
EP2545925A1 (en) * 2011-07-12 2013-01-16 Holy Stone Healthcare Co.,Ltd. Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases
WO2018044673A1 (en) * 2016-08-31 2018-03-08 Pharmunion, LLC A nutritional composition of pharmaceutical and dietary supplement containing said nutritional of pharmaceutical composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; April 2017 (2017-04-01), ARAGONA S E ET AL: "Regenerative medicine in the treatment of gastro-esophageal reflux disease and laryngo-pharyngeal reflux. From research to cure.", XP002779043, Database accession no. NLM28702984 *
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, vol. 31, no. 2 Suppl. 2, April 2017 (2017-04-01), pages 207 - 212, ISSN: 0393-974X *

Also Published As

Publication number Publication date
US20200085854A1 (en) 2020-03-19
WO2018215897A1 (en) 2018-11-29
MX2022015182A (es) 2023-01-30
PE20200526A1 (es) 2020-03-09
EP3630064A1 (en) 2020-04-08
MX2019013917A (es) 2020-07-28
EA201992743A1 (ru) 2020-03-13
MA48955A (fr) 2020-04-08
UA126580C2 (uk) 2022-11-02

Similar Documents

Publication Publication Date Title
LTC3057969I2 (lt) Kompozicijos, naudojamos gydyti sutrikimams, susijusiems su kit
DK3119397T3 (da) Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
ES2966825T3 (es) Activadores de piruvato quinasa para su uso en el tratamiento de trastornos sanguíneos
DK3882250T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
IT201600101413A1 (it) Composizione liquida per uso nel trattamento del reflusso gastroesofageo
IT201600121601A1 (it) Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
CL2015002897A1 (es) Inhibidores de bace1
DK3423060T3 (da) Imatinib til anvendelse til behandling af slagtilfælde
IT201600121617A1 (it) Composizione per il trattamento del reflusso gastroesofageo
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
DK3432901T3 (da) Sekventiel antikræftbehandling
IT201600081379A1 (it) Composizione farmaceutica per uso nel trattamento delle patologie prostatiche.
DK3700486T3 (da) Patientvendeapparat
DK3096775T3 (da) SOCS-mimetika til behandling af sygdomme
IT201700111939A1 (it) Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
SI3405197T1 (sl) Uporaba delgocitiniba za zdravljenje kroničnega ekcema rok
IT201700057635A1 (it) Composizione per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico
MA54630A (fr) N,n-bis-2-mercaptoéthyle isophtalamide pour le traitment des maladies neurodégénératives
GB2569682B (en) Topical composition for use in the treatment of burns
ITUA20162781A1 (it) Kit di medicamenti per l’uso nel trattamento di lesioni dei tessuti tegumentari.
PT3548006T (pt) Composição para utilização no tratamento de alterações intestinais
DK3639333T3 (da) Overfladebehandlingsindretning med ekspansionselektrodearrangement
ITUA20163037A1 (it) Formulazioni per uso nel trattamento o prevenzione di disturbi urologici
DOP2015000290A (es) Benzoxazoles sustituidos